Belden Inc.: Form 10-Q for the period ended Jul 4, 2021
Filed with the SEC on Aug 9, 2021 and accepted by EDGAR at Aug 9, 2021, 15:43 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-07-04. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-04-05 to 2021-07-04 | $602.0m | us-gaap:Revenues |
| Revenue | 6 months2021-01-01 to 2021-07-04 | $1.14bn | us-gaap:Revenues |
| Cost of revenue | 3 months2021-04-05 to 2021-07-04 | $390.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2021-01-01 to 2021-07-04 | $735.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-04-05 to 2021-07-04 | $211.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2021-01-01 to 2021-07-04 | $402.9m | us-gaap:GrossProfit |
| Research and development | 3 months2021-04-05 to 2021-07-04 | $30.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-01-01 to 2021-07-04 | $62.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-04-05 to 2021-07-04 | $105.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2021-01-01 to 2021-07-04 | $204.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-04-05 to 2021-07-04 | $66.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-01-01 to 2021-07-04 | $117.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-04-05 to 2021-07-04 | $8.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-01-01 to 2021-07-04 | $16.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-04-05 to 2021-07-04 | $43.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-01-01 to 2021-07-04 | $72.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-04-05 to 2021-07-04 | $0.97 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-01-01 to 2021-07-04 | $1.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-04-05 to 2021-07-04 | $0.98 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-01-01 to 2021-07-04 | $1.62 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-04-05 to 2021-07-04 | 45,262,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-01-01 to 2021-07-04 | 45,162,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-01-01 to 2021-07-04 | $26.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-01-01 to 2021-07-04 | $30.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2021-01-01 to 2021-07-04 | $4.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2021-07-04 | $423.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-07-04 | $1.16bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-07-04 | $3.27bn | us-gaap:Assets |
| Current liabilities | At period end2021-07-04 | $582.5m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2021-07-04 | $1.53bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2021-07-04 | $867.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000913142-21-000029. Last ingested by Listed: Oct 29, 2026, 14:50 ET. Listed shows no prices and gives no investment advice.